Big Move For Akari Therapeutics, Plc

Akari Therapeutics, Plc (AKTX:NASDAQ) rocketted at $18.27, representing a gain of 255.4%. On Fri, May 22, 2026, AKTX:NASDAQ hit a New 2-Week High of $18.27. The stock appeared on our News Catalysts scanner on Thu, May 21, 2026 at 07:23 PM in the 'BIOTECH' category. From Fri, May 08, 2026, the stock recorded 60.00% Up Days and 54.55% Green Days

About Akari Therapeutics, Plc (AKTX:NASDAQ)

Akari Therapeutics PLC is a biopharmaceutical company in clinical stage. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system.